Meditation app tested as tool to reduce risky behavior in juvenile offenders
NCT ID NCT05146167
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether teens on probation would use a meditation app called Bodhi AIM for one month. Researchers wanted to see if it was possible to collect data remotely on cannabis use, sexual health, and mental health. The study involved 107 teens aged 13-18 in Cook County, Illinois. It focused on whether the app was practical to use, not on whether it actually changed behavior.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Bodhi AIM smartphone app (mindfulness meditation)
- What this could lead to
- If successful, this could show that a simple app-based meditation program is a practical way to support teens in the legal system.
- What could go wrong
- This was a small feasibility study with only 107 participants, so results may not apply broadly. The app's impact on actual behavior change was not measured.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHAVIORAL HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital parenting Check-Up tame toddler tantrums?
- Parenting app put to the test: can it tame toddler tantrums and ease stress?
- Can a smartphone app ease stress for teens in the justice system?
- Can your smartwatch predict a stress breakdown?
- Can a meditation app curb cannabis use in At-Risk teens?
- Mindfulness program shows promise in preventing relapse, but tiny study limits conclusions